ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

NCI Virus Program Has “Important Extension of Virology” as New Approach To Etiology

April 23, 1976

“Do What’s Right for People With Cancer”. Glick’s Credo

May 24, 1996

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998